4//SEC Filing
ALBANY MOLECULAR RESEARCH INC 4
Accession 0001179110-15-003674
CIK 0001065087operating
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:45 PM ET
Size
8.5 KB
Accession
0001179110-15-003674
Insider Transaction Report
Form 4
Nolan Michael M
VP, CFO and Treasurer
Transactions
- Exercise/Conversion
Common Stock
2015-02-25$3.43/sh+5,000$17,150→ 73,318 total - Sale
Common Stock
2015-02-25$16.17/sh−5,000$80,850→ 68,318 total - Exercise/Conversion
Option to Purchase Common Stock
2015-02-25$3.43/sh+5,000$17,150→ 70,000 totalExercise: $3.43Exp: 2022-09-17→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]50% of grant is time based and 50% is performance based. Time based grant vests 25% per year on each of the first 4 anniversaries of the date of grant (September 12, 2012). Performance based grant vests 25% per year on each of the first 4 anniversaries of the grant date if (1) certain performance criteria related to the Company's operating profitability are reached and (2) the grantee is employed on such anniversary date; if the foregoing criteria are not met on the anniversary date, 25% of the shares of options under the performance award will immediately be forfeited. The 5,000 shares being exercised represent a portion of the vested grant.
Documents
Issuer
ALBANY MOLECULAR RESEARCH INC
CIK 0001065087
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001065087
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:45 PM ET
- Size
- 8.5 KB